×

CEO: THIS is biggest threat to pharm research...

6:42 AM ET Thu, 5 Nov 2015

Robert Mulroy, Merrimack CEO, discusses the risk factors and time element it takes to create innovative drugs as R&D costs rise and pharma consolidation continues.